Ziopharm Oncology reported $96.55M in Current Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US $ 24380M 5281M
Arena Pharmaceuticals ARNA:US $ 790.92M 199.52M
AstraZeneca AZN:LN 26.69B 583M
Baxter International BAX:US $ 8167M 163M
Biogen BIIB:US $ 7162.3M 21.4M
Bioline Rx BLRX:US $ 62.85M 4.23M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Corcept Therapeutics CORT:US $ 401.9M 9.37M
Curis CRIS:US $ 134.95M 21.58M
Eleven Biotherapeutics EBIO:US 200.48M 25.38M
Gilead Sciences GILD:US $ 14200M 275M
GlaxoSmithKline GSK:LN 18.25B 688M
Immunogen IMGN:US $ 296.8M 22.41M
Intrexon XON:US $ 153.09M 3.59M
Karyopharm Therapeutics KPTI:US $ 241.58M 31.92M
Novartis NOVN:VX 26.25B 2.45B
Ptc Therapeutics PTCT:US $ 1011.14M 55.09M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Sangamo Biosciences SGMO:US $ 447.4M 106.67M
Verastem VSTM:US $ 108.76M 6M
YTE INCY:US $ 2923.8M 303.74M
Ziopharm Oncology ZIOP:US $ 96.55M 7.15M